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In vivoa b s t r a c t
Rats were injected with rat recombinant (rr) IL3, rrSCF, rrIL-3 + rrSCF, rrRANTES and LTB4. Six hours after
subcutaneous injection of rrIL-3 or rrIL-3 + rrSCF, there was an increase in mast cell numbers in the skin
and spleen. Peritoneal mast cells were recruited following i.p. injection of rrIL-3, but with rrIL-3 + rrSCF
recruitment was delayed. Immunostaining with a mast cell speciﬁc antibody showed that immature
orthochromatic mast cells were being recruited. rrIL-3 induced recruitment of mast cells to the peritoneal
cavity was blocked by anti-integrin antibodies. Mast cell recruitment depended on the target tissue and
the time of exposure to the chemoattractant.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Mast cells are derived from pluripotent hematopoietic stem
cells in the bone marrow and migrate to peripheral tissues, where
they differentiate and complete their maturation under the inﬂu-
ence of the surrounding microenvironment [1,2]. Previous investi-
gations have shown the involvement of chemoattractants such as
IL-3 (Interleukin-3), SCF (Stem Cell Factor), RANTES (Regulated
on Activation Normal T cell Expressed and Secreted), and LTB4
(Leukotriene B4) in the recruitment of mast cells [2–9]. Recent re-
ports indicate that migration of immature mast cells may be one of
the key mechanisms responsible for the local accumulation of mast
cells [2,10,11]. The previous in vivo studies on chemokine induced
mast cell recruitment to peripheral tissues evaluated the effect of
only a single chemoattractant on mast cell recruitment. The pres-
ent study was undertaken to evaluate and compare the action of
various chemoattractants, either singly or in combination. The site
of administration and the differential effects of the chemoattrac-
tants on recruitment of mast cells to target tissues were character-
ized. The results show that although there were differences in mast
cell recruitment from site to site, regardless of the injection site,
rrIL-3 and the combination of rrIL-3 + rrSCF were the most effec-
tive chemoattractants in recruiting mast cells.2. Materials and methods
2.1. Animals
Male Wistar rats, 150 g, were used in this study. Animals
were housed and experiments were approved and conducted
according to FMRP-USP, Ribeirão Preto, São Paulo, Brazil guide-
lines (protocol: 085/2006). Animals were anesthetized with ket-
amine (80 mg/kg) plus xylazine (12 mg/kg) (Sigma Aldrich, St.
Louis, MO) prior to experimental treatment. All experiments
were performed in triplicate, with 3 animals in each experimen-
tal group. Animals injected with vehicle and submitted to similar
experimental conditions were used as negative controls. Animals
were euthanized by CO2 inhalation followed by cervical
dislocation.2.2. Mast cell recruitment
The chemoattractants rrIL-3, rrSCF, rrRANTES (all from Pepro-
tech Inc, Rocky Hill, NJ), LTB4 (Cayman Chemical, Ann Arbor, MI),
and rrIL-3 + rrSCF were injected subcutaneously in the rat dorsal
skin or i.p. (intraperitoneally) at a concentration of 350 ng/kg.
rrIL-3 and rrSCF were dissolved in PBS containing 0.1% BSA
(Sigma Aldrich), rrRANTES was dissolved in PBS and LTB4 in Tyr-
ode’s solution (140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mMMgCl2,
pH 7.4). For controls, animals were injected only with vehicle.
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Skin biopsies were collected with an 8 mm biopsy punch cen-
tered on the injection site and washed with PBS. The biopsies were
ﬁxed in 4% formaldehyde (Electron Microscopy Sciences, Hatﬁeld,
PA) in PBS and embedded in parafﬁn. Spleens were removed,
washed with PBS, cut into 5 mm slices, ﬁxed and embedded in par-
afﬁn. Mast cells were counted in the entire section of skin or spleen
following staining with 0.1% toluidine blue–1% acetic acid, pH 2.8
as previously described [10] using an Olympus BX 50 microscope
(Olympus America, Inc., Center Valley, PA). The area of each section
was then determined using Image-Pro Plus (Media Cybernetics,
Bethesda, MD). The peritoneal lavage was obtained and mast cells
were counted in a Neubauer camera after toluidine blue (pH 2.8)
staining. Cells obtained from the peritoneal cavity were also used
for histamine and ﬂow cytometry analyses.
2.4. Immunoﬂuorescence
For immunoﬂuorescence, 8 lm frozen sections of the skin
were ﬁxed with 2% formaldehyde in PBS for 15 min, washed in
PBS + 0.1 M glycine, blocked with PBS + 1% BSA containing 5 lg/
ml normal donkey IgG (Jackson ImmunoResearch, West Grove,
PA) for 45 min. Subsequently, the samples were incubated for
1 h with 5 lg/mL mAb AA4 [10], washed with PBS and incubated
for 30 min with donkey anti-mouse IgG conjugated to FITC (1:50
in PBS; Jackson ImmunoResearch). Coverslips were mounted
with Fluoromount G (Electron Microscopy Sciences) and sections
examined using an Olympus BX-50 microscope (Olympus Amer-
ica Inc.) equipped with a Spot RT-3 camera (Sterling Heights,
MI). Image-Pro Plus (Media Cybernetics) was used to record
the coordinates. After documentation, the coverslips were re-
moved, and the sections stained with toluidine blue (pH 2.8).
Again using Image-Pro Plus, the identical ﬁelds recorded in the
immunostained sections were located and documented in the
toluidine blue stained sections. Samples incubated only with la-
beled secondary antibody served as a control. All controls were
negative.
2.5. Flow cytometry
For ﬂow cytometry, the skin was dissociated according to the
method of Bradshaw et al. [12]. Following dissociation, the cells
were then ﬁxed with 2% formaldehyde, blocked with PBS + 1%
BSA for 45 min, and incubated with mAb AA4 (5 lg/ml) for 1 h.
Cells were washed and incubated with donkey anti-mouse IgG
conjugated to Cy5 (1:50 in PBS, Jackson ImmunoResearch) for
30 min. After incubation, the cells were washed in PBS and ana-
lyzed by ﬂow cytometry using a Becton–Dickinson FACSCalibur™
(Becton–Dickinson Biosciences, Bedford, MA) with CELLQuest soft-
ware. Samples incubated only with labeled secondary antibody
served as a control. All controls were negative.
2.6. Histamine assay
Histamine was extracted from the samples and the assays per-
formed as previously described [13]. Fluorescence intensity was
measured using the Histamine Module for the Trilogy Laboratory
Fluorometer (Turner Designs, Inc., Sunnyvale, CA).
2.7. Blocking mast cell recruitment
Antibodies against the a4 and b7 integrin subunits (Santa Cruz
Biotechnologies, Santa Cruz, CA), were used to block mast cell
recruitment. rrIL-3 was injected i.p. twice daily for 2, 6, and
10 days. Four hours before the administration of rrIL-3, animalsreceived an i.p. injection containing 15 lg each of anti-a4 and
anti-b7 antibodies diluted in 200 ll of HBSS (Hank’s Balanced Salt
Solution, Life Technologies). The animals were euthanized on days
3, 7 and 11, 24 h after the injection received on days 2, 6 and 10.
Control animals were injected i.p. with HBSS.2.8. Statistical analysis
The data are reported as mean ± standard error and statistically
analyzed by t-test or ANOVA using Tukey’s test. The differences be-
tween groups were determined using p-values. A p 6 0.05 was con-
sidered statistically signiﬁcant.3. Results
3.1. Mast cell recruitment to the skin
Six hours after subcutaneous injection of rrIL-3, rrRANTES, LTB4,
or rrIL-3 + rrSCF the number of metachromatic mast cells increased
signiﬁcantly in the dermis, as compared to controls (Fig. 1A). There
was only a slight increase in the number of mast cells with rrSCF
alone. Injection of rrIL-3 and rrIL-3 + rrSCF recruited more mast
cells to the skin than the other chemoattractants. At 6 h, this in-
crease in the mast cell population was paralleled by an increase
in histamine levels, especially after administration of rrIL-3 and
rrIL-3 + rrSCF (Fig. 1B). At 18 h after injection, although the number
of metachromatic mast cells in the skin was increased in compar-
ison to controls there was no difference among the chemoattrac-
tants (Fig. 1C). However, at 18 h the histamine levels varied
(Fig. 1D). Therefore, it appears that rrIL-3 and rrIL-3 + rrSCF were
the most effective chemokines in recruiting mast cells to the skin.
In order to characterize the population of mast cells that were
recruited to the skin after rrIL-3 and rrIL-3 + rrSCF injection, the tis-
sue was dissociated and the cells were labeled with mAbAA4,
which recognizes mature, immature and very immature mast cells
that contain only a few orthochromatic granules. At 6 h after injec-
tion, as determined by ﬂow cytometry, the AA4+ mast cell popula-
tion increased approximately 10-fold with rrIL-3 and 8-fold with
rrIL-3 + rrSCF (Fig. 2A). When skin sections were immunostained
with mAb AA4 (Fig. 2B) followed by staining with toluidine blue
(Fig. 2C), mature mast cells could be identiﬁed with both methods,
but there was a population of small, apparently immature mast
cells, that were labeled only with mAb AA4. Some of these small
AA4+ mast cells were associated with the base of the hair follicles
(Fig. 2B). Thus, the increase in mast cell numbers following rrIL-3
or rrIL-3 + rrSCF injection appears to be due at least partly to the
recruitment of immature mast cells.3.2. Mast cell recruitment to the spleen
A signiﬁcant increase in the number of metachromatic mast
cells was observed in the spleen, 6 h after subcutaneous injection
of rrIL-3 or rrIL-3 + rrSCF when compared to the controls
(Fig. 3A). No signiﬁcant increase in the number of mast cells was
seen with rrSCF, LTB4 or rrRANTES. Eighteen hours after subcuta-
neous injection, there were notable changes in the mast cell num-
bers depending on the chemoattractant (Fig. 3B). At 18 h, the mast
cell numbers in the spleens of animals injected with rrIL-3 + rrSCF
increased 260% when compared to 6 h. An increase was also ob-
served at 18 h after injection of RANTES (260%) or LTB4 (151%).
In contrast, animals injected only with rrIL-3 showed a 63.5%
reduction in the number of mast cells when compared to 6 h.
Fig. 1. Subcutaneous injection of chemoattractants results in enhanced mast cell recruitment to the skin. Animals were euthanized 6 h (A and B) or 18 h (C and D) after
subcutaneous injection of chemoattractants in the rat dorsal skin and the number of mast cells/30 mm2 and histamine levels were determined in skin biopsies. The data
shown is the mean ± SE of 3 separate experiments. ⁄p 6 0.05 (A and B), ⁄p < 0.1 (C and D).
Fig. 2. rrIL-3 increases the number of AA4+ mast cells in the dermis after subcutaneous injection. Animals were euthanized 6 h after subcutaneous injection of rrIL-3 or rrIL-
3 + rrSCF in the rat dorsal skin. (A) For ﬂow cytometry mast cells were immunolabeled with mAb AA4-Cy5. The results shown are from 3 independent experiments. 100,000
cells/data point were analyzed ⁄p 6 0.05. (B) Mast cells were immunolabed with mAb AA4-FITC. Mature (arrows) and small immature AA4+ mast cells (arrowheads) are found
close to the hair follicle (HF). (C) The same ﬁeld immunolabeled in B is shown stained with toluidine blue. Only the mature mast cell is metachromatic.
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The percent of mast cells in the peritoneal cavity increased sig-
niﬁcantly 6 h after i.p. injection of rrIL-3 (Fig. 3C). At 18 h (Fig. 3D)
the percentage of peritoneal mast cells after i.p. injection of rrIL-3
had dropped by 34.2% in comparison to 6 h. In contrast, at this
same time animals injected with RANTES showed a signiﬁcant in-
crease (168.61%) in the percentage of peritoneal mast cells
(Fig. 3D). In general, the histamine levels paralleled the percentage
of mast cells present (data not shown).
3.4. Mast cell recruitment to the peritoneal cavity in response to rrIL-3
decreases with time
The recruitment of mast cells to the peritoneal cavity was
further investigated in animals that received rrIL-3 for extendedperiods of time: 2, 6 and 10 days (Fig. 4). After injection of the
chemoattractant for 2 days, there was a signiﬁcant increase in
the percentage of metachromatic mast cells in the peritoneal la-
vage (Fig. 4A). However, a reduction in the metachromatic mast
cell population occurred 6 days after repeated injections of rrIL-
3. After 10 days of injections, the percentage of metachromatic
mast cells in the peritoneal cavity had decreased further. The
same pattern was seen by ﬂow cytometry after immunolabeling
with mAb AA4 (Fig. 4B). However, more mast cells were de-
tected especially at 10 days by ﬂow cytometry than were seen
with toluidine blue staining. This is consistent with the results
obtained in the skin (Fig. 2) and most likely represents the
recruitment of immature mast cells to the peritoneal cavity.
The histamine levels were in general agreement with the per-
centage of mast cells in the peritoneal cavity (data not shown).
Fig. 3. Chemoattractants are less efﬁcient in recruiting mast cells to the spleen and peritoneal cavity. Spleen: animals were euthanized at 6 h (A) and 18 h (B) after
subcutaneous injection of chemoattractants in the dorsal skin and the number of mast cells/30 mm2 were determined. Peritoneal cavity: Animals were euthanized at 6 h (C)
and 18 h (D) after i.p. injection of the chemoattractants and the percentage of peritoneal mast cells determined. The data shown is the mean ± SE of 3 separate
experiments.⁄Signiﬁcant at p 6 0.05.
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integrin dependent
Since it is known that integrins are necessary for mast cell
recruitment [14–17], it was of interest to determine if integrins
played a role in the recruitment of mast cells by rrIL-3. Therefore,
animals were treated with anti-integrin subunit antibodies prior to
injection of rrIL-3. Mast cell recruitment to the peritoneal cavity by
rrIL-3 was signiﬁcantly reduced by i.p. injection of antibodies
against the integrin subunits a4 and b7. After injection of the
anti-integrin subunit antibodies, the metachromatic mast cell pop-
ulation diminished by 82.6 ± 6.3% at 2 days, 80.3 ± 7.6% at 6 days
and 69.1 ± 11.9% at 10 days when compared to animals that re-
ceived only rrIL-3 (Fig. 4A). The reduction in mast cell recruitment
by anti-integrin subunits a4 and b7 was conﬁrmed by ﬂow cytom-
etry of mast cells immunolabeled with mAb AA4 (Fig. 4B).4. Discussion
The present investigation is the ﬁrst to provide direct evidence
in vivo that differences exist in the efﬁciency of various cytokines
to recruit mast cells. In the present study, the combination of rrIL-3
and rrSCF proved to be the most effective in recruiting mast cells.
Previously, the action of each mast cell chemoattractant in vivo has
been examined individually. After intraperitoneal injection of IL-3,
an increase of 10–100-fold in the number of mast cells in the
spleen was seen [18]. With subcutaneous injection of SCF into
mice, there was a local increase in mast cells. However, systemic
administration of SCF in rats resulted in a striking increase in mastcells at all peripheral sites examined including skin, spleen and the
peritoneal cavity [8]. Conti et al. observed an increase in the pop-
ulation of mast cells in the soleus muscle of rats after either subcu-
taneous injection [5] or intramuscular injection [19] of rrRANTES.
An unexpected result in the present study was the low level of
mast cell recruitment seen with SCF alone. Studies with bone mar-
row derived mast cells, in vitro, have shown that preincubation
with IgE inhibited SCF induced chemotaxis [20]. Since mast cells
in vivo normally have IgE bound to their surface, this bound IgE
may inhibit SCF induced mast cell recruitment in vivo.
The use of a mast cell speciﬁc antibody, mAb AA4, showed the
presence of immature mast cells [10] following cytokine adminis-
tration. These immature mast cells are similar to those seen in
other studies and were orthochromatic and could not be detected
with toluidine blue. The present study shows that without the use
of mAb AA4, the number of mast cells present after chemoattrac-
tant administration is underestimated.
The results of the present study agree with other published re-
ports that mast cell recruitment is integrin dependent. In the pres-
ent study, intraperitoneal injection of antibodies against the
integrin subunits a4 and b7 reduced the recruitment of mast cells,
even after stimulation with rrIL-3. In previous investigations, a4b7
integrin has been shown to be essential for tissue speciﬁc homing
of intestinal mast cell progenitors [16]. Administration of anti-inte-
grin subunits a4 and b7 antibodies inhibited 83% and 73%,
respectively, the number of mast cells recruited to the lungs of
ovalbumin-sensitized and challenged mice [14].
The in vivo recruitment of mature and immature mast cells by
cytokines is dependent on the target site, the time of exposure and
is mediated by integrins. The use of cytokines in vivo may help to
Fig. 4. Mast cell recruitment to the peritoneal cavity in response to rrIL-3 decreases
with time and is integrin dependent. The animals received two daily doses, i.p., of
rrIL-3 for 2, 6, and 10 days and were euthanized 24 h after the last injection. For
some experiments, animals received two daily doses of antibodies against a4 and
b7 integrin subunits before the rrIL-3. The percentage of metachromatic mast cells
(A) was determined by toluidine blue staining and the percentage of AA4+ mast
cells (B) by ﬂow cytometry. Control animals were injected, i.p., with vehicle. The
data shown is the mean ± SE of 3 separate experiments. ⁄p 6 0.05.
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hyperplasia that occur during allergy, asthma, parasitic, and other
inﬂammatory processes.
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